# Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)

> **NCT06296056** · PHASE1 · COMPLETED · sponsor: **Seoul Hospital** · enrollment: 9 (actual)

## Conditions studied

- Solid Tumors
- Metastatic

## Interventions

- **BIOLOGICAL:** Combi

## Key facts

- **NCT ID:** NCT06296056
- **Lead sponsor:** Seoul Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-01
- **Primary completion:** 2025-05-28
- **Final completion:** 2025-06-08
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06296056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06296056, "Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06296056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*